Stock Price
53.13
Daily Change
-0.35 -0.65%
Monthly
-6.77%
Yearly
-3.15%
Q2 Forecast
51.53

Bio Techne reported $2.01B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Agilent USD 6.91B 167M Dec/2025
Becton, Dickinson and Co. USD 25.28B 108M Dec/2025
Bio Techne USD 2.01B 45.18M Dec/2025
Bio-Rad Laboratories USD 7.45B 716.8M Dec/2025
Bruker USD 2.49B 625.6M Sep/2025
Charles River Laboratories USD 3.16B 240.82M Dec/2025
Danaher USD 52.53B 1.46B Dec/2025
Hologic USD 5.25B 197.2M Dec/2025
Illumina USD 2.72B 342M Dec/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
Merck EUR 28.59B 344M Dec/2025
Mettler Toledo International USD -23.64M 225.56M Dec/2025
OraSure Technologies USD 340.83M 21.15M Dec/2025
Pacific Biosciences Of California USD 5.35M 30.74M Dec/2025
Repligen USD 2.11B 1.66B Dec/2025
Revvity USD 7.38B 180.27M Sep/2025
Standard Biotools USD 424.29M 24.63M Dec/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
Waters USD 2.56B 230.55M Dec/2025